The research aims to explore the effectiveness of BP@CS nanoparticles in regulating reactive oxygen species to treat corneal neovascularization.
Local subconjunctival injection of BP@CS nanoparticles
Assessment of neovascularization levels after corneal injury
Evaluation of reactive oxygen species regulation
Successful reduction of neovascularization observed after treatment with nanoparticles
Sustained regulation of reactive oxygen species was achieved
Demonstrated potential for a new therapeutic approach in corneal injuries
Abstract
The administration of BP@CS nanoparticles for sustained ROS regulation through local subconjunctival injection represents a new approach to the treatment of pathological corneal neovascularization.